The Danish company’s share price rise of 7 per cent this year lags far behind its rival Eli Lilly’s 36 per cent, as the US company has gradually increased its share of the obesity and diabetes market ...

and sometimes people are told to change their diabetes treatment. If you or your family member start a new diabetes treatment, make sure to ask the right questions from the doctor. Let us tell you ...

With the FDA approval of the first specific drug for Metabolic Associated Steatohepatitis (MASH) in March this year, Madrigal’s Rezdiffra is a pioneer in a market set for rapid change. | With the FDA ...

"There is hope, including advances in early detection and treatment spearheaded by retina specialists that can help people ...

Six/UW/Seattle Children’s Cancer Consortium scientists received new funding from the Breast Cancer Research Foundation to ...

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

In 2025, children within the TEDDY study will submit their final samples at research clinics in Sweden, Finland, Germany and ...

Topline results were announced from a cardiovascular outcomes study evaluating oral semaglutide in patients with type 2 diabetes.

SAN ANTONIO — Treatment with once-weekly semaglutide 2.4 mg (Wegovy ... in people with overweight/obesity and established cardiovascular disease (CVD). The new findings come from prespecified analyses ...

Doctors are currently using stem cells to treat a variety of medical conditions — and that list could soon become even larger ...

For years, scientists have observed a connection between type 2 diabetes and an increased risk of dementia, particularly ...